BHVN BIOHAVEN LTD revenue, earnings and financials
For the quarter ended June 30, 2026, BIOHAVEN LTD reported revenue of n/a, net income of −$137M and diluted EPS of −$0.91; for the fiscal year ended December 2025 revenue was n/a.
BHVN annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$745M, net income −$739M (margin n/a), EPS −$6.86
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$885M, net income −$846M (margin n/a), EPS −$9.28
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$436M, net income −$408M (margin n/a), EPS −$5.73
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$568M, net income −$570M (margin n/a), EPS −$12.75
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$219M, net income −$214M (margin n/a), EPS −$5.43
BHVN quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$137M, EPS −$0.91
- Quarter ended Mar 31, 2026: revenue n/a, net income −$131M, EPS −$0.88
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$146M, EPS −$1.11
- Quarter ended Sep 30, 2025: revenue n/a, net income −$173M, EPS −$1.64
- Quarter ended Jun 30, 2025: revenue n/a, net income −$198M, EPS −$1.94
- Quarter ended Mar 31, 2025: revenue n/a, net income −$222M, EPS −$2.17
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$187M, EPS −$1.74
- Quarter ended Sep 30, 2024: revenue n/a, net income −$160M, EPS −$1.70
- Quarter ended Jun 30, 2024: revenue n/a, net income −$320M, EPS −$3.64
- Quarter ended Mar 31, 2024: revenue n/a, net income −$180M, EPS −$2.20
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$145M, EPS −$1.88
- Quarter ended Sep 30, 2023: revenue n/a, net income −$103M, EPS −$1.50
- Quarter ended Jun 30, 2023: revenue n/a, net income −$90.3M, EPS −$1.32
- Quarter ended Mar 31, 2023: revenue n/a, net income −$70.5M, EPS −$1.03
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$201M, EPS −$3.38
- Quarter ended Sep 30, 2022: revenue n/a, net income −$68.9M, EPS −$1.75
- Quarter ended Jun 30, 2022: revenue n/a, net income −$203M, EPS −$5.16
- Quarter ended Mar 31, 2022: revenue n/a, net income −$97.0M, EPS −$2.46
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$51.9M, EPS n/a
- Quarter ended Sep 30, 2021: revenue n/a, net income −$54.4M, EPS −$1.38
BHVN cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$609M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$582M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$332M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$298M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$146M, share buybacks n/a
BHVN balance sheet
- Jun 30, 2026: cash $238M, total assets $371M, total liabilities $359M, shareholders' equity $12.2M
- Mar 31, 2026: cash $273M, total assets $466M, total liabilities $337M, shareholders' equity $130M
- Dec 31, 2025: cash $230M, total assets $451M, total liabilities $399M, shareholders' equity $52.1M
- Sep 30, 2025: cash $185M, total assets $409M, total liabilities $426M, shareholders' equity −$17.2M
- Jun 30, 2025: cash $166M, total assets $550M, total liabilities $416M, shareholders' equity $135M
- Mar 31, 2025: cash $98.4M, total assets $459M, total liabilities $199M, shareholders' equity $259M
- Dec 31, 2024: cash $99.1M, total assets $615M, total liabilities $192M, shareholders' equity $423M
- Sep 30, 2024: cash $84.4M, total assets $511M, total liabilities $195M, shareholders' equity $316M
Is BHVN profitable?
No. BIOHAVEN LTD lost $587M over the last four quarters.
What is BHVN's EPS?
Diluted earnings per share over the last four quarters were −$4.54; −$0.91 in the latest quarter.